Warts and all: Human papillomavirus in primary immunodeficiencies

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 5, 2012, Pages 1030-1048

  Leiding, Jennifer W ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

carcinoma; dysplastic; human papillomavirus; Immunodeficiency; squamous; warts

Indexed keywords

CELL CYCLE PROTEIN; CHEMOKINE RECEPTOR CXCR4; DEDICATOR OF CYTOKINESIS 8; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ATAXIA TELANGIECTASIA; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE SEVERITY; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER1 GENE; EVER2 GENE; GENE; GENE MUTATION; HUMAN; HYPER IGE SYNDROME; IDIOPATHIC CD4 LYMPHOPENIA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; INCIDENCE; INFECTION SENSITIVITY; LYMPHEDEMA; LYMPHOCYTOPENIA; NETHERTON DISEASE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SEVERE COMBINED IMMUNODEFICIENCY; VERRUCA VULGARIS; WART VIRUS; WISKOTT ALDRICH SYNDROME;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MEMBRANE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; PROTEINASE INHIBITORY PROTEINS, SECRETORY; RECEPTORS, CXCR4; RISK FACTORS; TUMOR VIRUS INFECTIONS; WARTS;

EID: 84869128682     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.07.049     Document Type: Review

References (201)

1. J.C. Sterling, S. Handfield-Jones, and P.M. Hudson Guidelines for the management of cutaneous warts Br J Dermatol 144 2001 4 11 (Pubitemid 32162085)
2. F.M. van Haalen, S.C. Bruggink, J. Gussekloo, W.J. Assendelft, and J.A. Eekhof Warts in primary schoolchildren: prevalence and relation with environmental factors Br J Dermatol 161 2009 148 152
3. H.C. Williams, A. Pottier, and D. Strachan The descriptive epidemiology of warts in British schoolchildren Br J Dermatol 128 1993 504 511 (Pubitemid 23155946)
4. J.N. Rea, M.L. Newhouse, and T. Halil Skin disease in Lambeth. A community study of prevalence and use of medical care Br J Prev Soc Med 30 1976 107 114
5. J.T. Kainz, G. Kozel, M. Haidvogl, and J. Smolle Homoeopathic versus placebo therapy of children with warts on the hands: a randomized, double-blind clinical trial Dermatology 193 1996 318 320 (Pubitemid 27007575)
6. A.M. Massing, and W.L. Epstein Natural history of warts. A two-year study Arch Dermatol 87 1963 306 310
7. L. Leung Recalcitrant nongenital warts Aust Fam Physician 40 2011 40 42
8. C.J. Lacey Therapy for genital human papillomavirus-related disease J Clin Virol 32 suppl 1 2005 S82 S90
9. R.L. Winer, N.B. Kiviat, J.P. Hughes, D.E. Adam, S.K. Lee, and J.M. Kuypers Development and duration of human papillomavirus lesions, after initial infection J Infect Dis 191 2005 731 738 (Pubitemid 40271061)
10. A.R. Giuliano, G. Tortolero-Luna, E. Ferrer, A.N. Burchell, S. de Sanjose, and S.K. Kjaer Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions Vaccine 26 suppl 10 2008 K17 K28
11. T. Tanigaki, and H. Endo A case of epidermodysplasia verruciformis (Lewandowsky-Lutz, 1922) with skin cancer - histopathology of malignant cutaneous changes Dermatologica 169 1984 97 101 (Pubitemid 14086383)
12. W.R.P. de Oliveira, C.F. Neto, P.L. Rady, and S.K. Tyring Clinical aspects of epidermodysplasia verruciformis J Eur Acad Dermatol Venereol 17 2003 394 398 (Pubitemid 36869300)
13. G. Orth Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses Semin Immunol 18 2006 362 374 (Pubitemid 44511885)
14. A. Antonsson, S. Karanfilovska, P.G. Lindqvist, and B.G. Hansson General acquisition of human papillomavirus infections of skin occurs in early infancy J Clin Microbiol 41 2003 2509 2514 (Pubitemid 36712461)
15. G. Astori, D. Lavergne, C. Benton, B. Hockmayr, K. Egawa, and C. Garbe Human papillomaviruses are commonly found in normal skin of immunocompetent hosts J Invest Dermatol 110 1998 752 755 (Pubitemid 28194022)
16. S. Majewski, E. Skopinska-Rozewska, S. Jablonska, M. Wasik, J. Misiewicz, and G. Orth Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis J Am Acad Dermatol 15 1986 966 973 (Pubitemid 17176809)
17. W.R.P. de Oliveira, S. Carrasco, C.F. Neto, P. Rady, and S.K. Tyring Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis J Dermatol 30 2003 203 209 (Pubitemid 36417548)
18. W. Glinski, S. Jablonska, A. Langner, S. Obalek, M. Haftek, and M. Proniewska Cell-mediated immunity in epidermodysplasia verruciformis Dermatologica 153 1976 218 227
19. W. Glinski, S. Obalek, S. Jablonska, and G. Orth T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5 Dermatologica 162 1981 141 147 (Pubitemid 11105838)
20. M. Haftek, S. Jablonska, and G. Orth Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts Dermatologica 170 1985 213 220 (Pubitemid 15099817)
21. S.E. Prawer, F. Pass, J.C. Vance, L.J. Greenberg, E.J. Yunis, and A.S. Zelickson Depressed immune function in epidermodysplasia verruciformis Arch Dermatol 113 1977 495 499 (Pubitemid 8071614)
22. S. Pyrhonen, S. Jablonska, S. Obalek, and E. Kuismanen Immune reactions in epidermodysplasia verruciformis Br J Dermatol 102 1980 247 254 (Pubitemid 10138642)
23. K.D. Cooper, E.J. Androphy, D. Lowy, and S.I. Katz Antigen presentation and T-cell activation in epidermodysplasia verruciformis J Invest Dermatol 94 1990 769 776 (Pubitemid 20184376)
24. M. Kaminski, M. Pawinska, S. Jablonska, A. Szmurlo, S. Majewski, and G. Orth Increased natural killer cell activity in patients with epidermodysplasia verruciformis Arch Dermatol 121 1985 84 86 (Pubitemid 16225026)
25. S. Majewski, J. Malejczyk, S. Jablonska, J. Misiewicz, L. Rudnicka, and S. Obalek Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis J Am Acad Dermatol 22 1990 423 427 (Pubitemid 20212394)
26. W.R. de Oliveira, P.L. Rady, J. Grady, T.K. Hughes, C. Festa Neto, and E.A. Rivitti Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis J Am Acad Dermatol 49 2003 639 643 (Pubitemid 37210276)
27. E.J. Androphy, I. Dvoretzky, and D.R. Lowy X-Linked Inheritance of epidermodysplasia verruciformis - genetic and virologic studies of a kindred Arch Dermatol 121 1985 864 868 (Pubitemid 15070196)
28. D.F. McDermott, B. Gammon, P.J. Snijders, I. Mbata, B. Phifer, and A.H. Hartley Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation Pediatr Dermatol 26 2009 306 310
29. N. Ramoz, L.A. Rueda, B. Bouadjar, L.S. Montoya, G. Orth, and M. Favre Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis Nat Genet 32 2002 579 581 (Pubitemid 35435168)
30. M. Lazarczyk, P. Cassonnet, C. Pons, Y. Jacob, and M. Favre The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections Microbiol Mol Biol Rev 73 2009 348 370
31. S. Vohra, N.L. Sharma, V. Shanker, V.K. Mahajan, and N. Jindal Autosomal dominant epidermodysplasia verruciformis: a clinicotherapeutic experience in two cases Indian J Dermatol Venereol Leprol 76 2010 557 561
32. C. Berthelot, M.C. Dickerson, P. Rady, Q. He, F. Niroomand, and S.K. Tyring Treatment of a patient with epidermodysplasia verrucifomis carrying a novel EVER2 mutation with imiquimod J Am Acad Dermatol 56 2007 882 886 (Pubitemid 46561022)
33. J. Hayashi, C. Matsui, T. Mitsuishi, M. Kawashima, and M. Morohashi Treatment of localized epidermodysplasia verruciformis with tacalcitol ointment Int J Dermatol 41 2002 817 820 (Pubitemid 35422854)
34. R. Anadolu, T. Oskay, C. Erdem, A. Boyvat, E. Terzi, and E. Gurgey Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a J Am Acad Dermatol 45 2001 296 299 (Pubitemid 32729317)
35. G. Micali, M.R. Nasca, F. Dall'Oglio, and M.L. Musumeci Cimetidine therapy for epidermodysplasia verruciformis J Am Acad Dermatol 48 suppl 2003 S9 S10
36. S. Karrer, R.M. Szeimies, C. Abels, U. Wlotzke, W. Stolz, and M. Landthaler Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy Br J Dermatol 140 1999 935 938 (Pubitemid 29238471)
37. M.A. Lutzner Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis Bull Cancer 65 1978 169 182
38. S. Jablonsk, K. Jakubowi, and J. Dabrowsk Epidermodysplasia verruciformis as a model in studies on role of papovaviruses in oncogenesis Cancer Res 32 1972 583
39. W.W. Zuelzer "Myelokathexis" - a new form of chronic granulocytopenia. Report of a case N Engl J Med 270 1964 699 704
40. C.E. Krill Jr., H.D. Smith, and A.M. Mauer Chronic Idiopathic Granulocytopenia N Engl J Med 270 1964 973 979
41. T. Kawai, and H.L. Malech WHIM syndrome: congenital immune deficiency disease Curr Opin Hematol 16 2009 20 26
42. M.D. Tarzi, M. Jenner, K. Hattotuwa, A.Z. Faruqi, G.A. Diaz, and H.J. Longhurst Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome J Allergy Clin Immunol 116 2005 1101 1105 (Pubitemid 41571795)
43. K. Balabanian, B. Lagane, J.L. Pablos, L. Laurent, T. Planchenault, and O. Verola WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 Blood 105 2005 2449 2457 (Pubitemid 40387045)
44. K.M. Chae, J.O. Ertle, and M.D. Tharp B-cell lymphoma in a patient with WHIM syndrome J Am Acad Dermatol 44 2001 124 128 (Pubitemid 32110576)
45. S. Imashuku, A. Miyagawa, T. Chiyonobu, H. Ishida, T. Yoshihara, and T. Teramura Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis Ann Hematol 81 2002 470 473 (Pubitemid 36067662)
46. G.A. Diaz CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 203 2005 235 243 (Pubitemid 40179704)
47. R.J. Gorlin, B. Gelb, G.A. Diaz, K.G. Lofsness, M.R. Pittelkow, and J.R. Fenyk Jr. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies Am J Med Genet 91 2000 368 376 (Pubitemid 30193934)
48. A.V. Gulino, D. Moratto, S. Sozzani, P. Cavadini, K. Otero, and L. Tassone Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome Blood 104 2004 444 452 (Pubitemid 38900027)
49. P.A. Hernandez, R.J. Gorlin, J.N. Lukens, S. Taniuchi, J. Bohinjec, and F. Francois Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease Nat Genet 34 2003 70 74 (Pubitemid 36548793)
50. B. Lagane, K.Y. Chow, K. Balabanian, A. Levoye, J. Harriague, and T. Planchenault CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome Blood 112 2008 34 44
51. K. Balabanian, A. Levoye, L. Klemm, B. Lagane, O. Hermine, and J. Harriague Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling J Clin Invest 118 2008 1074 1084 (Pubitemid 351364615)
52. J.L. Pablos, A. Amara, A. Bouloc, B. Santiago, A. Caruz, and M. Galindo Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin Am J Pathol 155 1999 1577 1586
53. L. Tassone, D. Moratto, W. Vermi, M. De Francesco, L.D. Notarangelo, and F. Porta Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients Blood 116 2010 4870 4873
54. B. Weston, R.A. Axtell, R.F. Todd 3rd, M. Vincent, K.J. Balazovich, and S.J. Suchard Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis J Pediatr 118 1991 229 234
55. M. Wetzler, M. Talpaz, M.J. Kellagher, J.U. Gutterman, and R. Kurzrock Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF JAMA 267 1992 2179 2180
56. D.H. McDermott, Q. Liu, J. Ulrick, N. Kwatemaa, S. Anaya-O'Brien, and S.R. Penzak The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome Blood 118 2011 4957 4962
57. E.Y. Chu Cutaneous manifestations of DOCK8 deficiency syndrome Arch Dermatol 148 2012 79 84
58. K.R. Engelhardt, S. McGhee, S. Winkler, A. Sassi, C. Woellner, and G. Lopez-Herrera Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome J Allergy Clin Immunol 124 2009 1289 1302 e4
59. Q. Zhang, J.C. Davis, C.G. Dove, and H.C. Su Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome Dis Markers 29 2010 131 139
60. H.C. Su Combined immunodeficiency associated with DOCK8 mutations and related immunodeficiencies Dis Markers 29 2010 121 122
61. T. Lambe, G. Crawford, A.L. Johnson, T.L. Crockford, T. Bouriez-Jones, and A.M. Smyth DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory Eur J Immunol 41 2011 3423 3435
62. T. Chatila, S. Al Khatib, S. Keles, M. Garcia-Lioret, E.K. Koc-Aydiner, and I. Reisli Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome J Allergy Clin Immunol 124 2009 342 348
63. H.C. Su Dedicator of cytokinesis 8 (DOCK8) deficiency Curr Opin Allergy Clin Immunol 10 2010 515 520
64. S.A. Gatz, U. Benninghoff, C. Schutz, A. Schulz, M. Honig, and U. Pannicke Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation Bone Marrow Transplant 46 2011 552 556
65. Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection - United States MMWR Morb Mortal Wkly Rep 41 1992 541 545
66. D.I. Zonios, J. Falloon, J.E. Bennett, P.A. Shaw, D. Chaitt, and M.W. Baseler Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors Blood 112 2008 287 294
67. E. Gubinelli, P. Posteraro, and G. Girolomoni Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata J Dermatol 29 2002 653 656 (Pubitemid 35334013)
68. E.R. Hansen, S. Lisby, O. Baadsgaard, V.C. Ho, E.M. de Villiers, and G.L. Vejlsgaard Abnormal function of CD4+ helper/inducer T lymphocytes in a patient with widespread human papillomavirus type 3-related infection Arch Dermatol 126 1990 1604 1608
69. P. Manchado Lopez, J.M. Ruiz de Morales, I. Ruiz Gonzalez, and M.A. Rodriguez Prieto Cutaneous infections by papillomavirus, herpes zoster and Candida albicans as the only manifestation of idiopathic CD4+ T lymphocytopenia Int J Dermatol 38 1999 119 121 (Pubitemid 29136863)
70. L. Requena, J.L. Sarasa, M. Terai, T. Sata, and T. Matsukura Lifelong severe verrucosis associated with human papillomavirus type 2: report of a case with a 38-year follow-up Br J Dermatol 139 1998 1081 1086 (Pubitemid 29010552)
71. C.L. Stetson, R.P. Rapini, S.K. Tyring, and R.C. Kimbrough CD4+ T lymphocytopenia with disseminated HPV J Cutan Pathol 29 2002 502 505 (Pubitemid 35034462)
72. S. Pasic, P. Minic, S. Dzudovic, A. Minic, and B. Slavkovic Idiopathic CD4+ lymphocytopenia and juvenile laryngeal papillomatosis Pediatr Pulmonol 39 2005 281 283 (Pubitemid 40460699)
73. R.B. Salit, K.G. Hankey, R. Yi, A.P. Rapoport, and D.L. Mann Detection of CD4(+) T-cell antibodies in a patient with idiopathic CD4 T lymphocytopenia and cryptococcal meningitis Br J Haematol 139 2007 133 137 (Pubitemid 47389939)
74. C. Vicente, A. Conchillo, M.A. Garcia-Sanchez, and M.D. Odero The role of the GATA2 transcription factor in normal and malignant hematopoiesis Crit Rev Oncol Hematol 82 2012 1 17
75. N.P. Rodrigues, V. Janzen, R. Forkert, D.M. Dombkowski, A.S. Boyd, and S.H. Orkin Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis Blood 106 2005 477 484 (Pubitemid 40981241)
76. V. Bigley, M. Haniffa, S. Doulatov, X.N. Wang, R. Dickinson, and N. McGovern The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency J Exp Med 208 2011 227 234
77. C.N. Hahn, C.E. Chong, C.L. Carmichael, E.J. Wilkins, P.J. Brautigan, and X.C. Li Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia Nat Genet 43 2011 1012 1017
78. D.C. Vinh, S.Y. Patel, G. Uzel, V.L. Anderson, A.F. Freeman, and K.N. Olivier Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia Blood 115 2010 1519 1529
79. J.M. Emberger, M. Navarro, M. Dejean, and P. Izarn Deaf-mutism, lymphedema of the lower limbs and hematological abnormalities (acute leukemia, cytopenia) with autosomal dominant transmission [in French] J Genet Hum 27 1979 237 245 (Pubitemid 10175602)
80. R.E. Dickinson, H. Griffin, V. Bigley, L.N. Reynard, R. Hussain, and M. Haniffa Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency Blood 118 2011 2656 2658
81. A.P. Hsu, E.P. Sampaio, J. Khan, K.R. Calvo, J.E. Lemieux, and S.Y. Patel Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome Blood 118 2011 2653 2655
82. P. Ostergaard, M.A. Simpson, F.C. Connell, C.G. Steward, G. Brice, and W.J. Woollard Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) Nat Genet 43 2011 929 931
83. M. Attal, F. Huguet, C. Nouvel, N. Dastugue, G. Laurent, and E. Duchayne Idiopathic lymphoedema associated with familial acute-leukemia - a new case [in French] Presse Med 14 1985 600
84. S. Drony, F. Bauters, B. Barthel, M. Moriceau, and C. Sarrazin 2 Family cases of congenital elephantiasis with acute myeloid-leukemia Nouvelle Revue Francaise D Hematologie 25 1983 184
85. S. Gaillard, D. Bordessoule, G. Malinvaud, and C. Verger Preleukemic dyshematopoiesis and congenital lymphedema Nouvelle Revue Francaise D Hematologie 25 1983 184
86. S. Mansour, F. Connell, C. Steward, P. Ostergaard, G. Brice, and S. Smithson Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases Am J Med Genet 152A 2010 2287 2296
87. J. Cuellar-Rodriguez, J. Gea-Banacloche, A.F. Freeman, A.P. Hsu, C.S. Zerbe, and K.R. Calvo Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency Blood 118 2011 3715 3720
88. K.R. Calvo, D.C. Vinh, I. Maric, W. Wang, P. Noel, and M. Stetler-Stevenson Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications Haematologica 96 2011 1221 1225
89. R.S. Ostrow, D. Manias, A.J. Mitchell, L. Stawowy, and A.J. Faras Epidermodysplasia verruciformis. A case associated with primary lymphatic dysplasia, depressed cell-mediated immunity, and Bowen's disease containing human papillomavirus 16 DNA Arch Dermatol 123 1987 1511 1516
90. A. Kreuter, B. Hochdorfer, N.H. Brockmeyer, P. Altmeyer, H. Pfister, and U. Wieland A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome Arch Dermatol 144 2008 366 372 (Pubitemid 351439120)
91. R.D. Wilkinson, G.H. Curtis, and W.A. Hawk Netherton's disease; trichorrhexis invaginata (bamboo hair), congenital ichthyosiform erythroderma and the atopic diathesis. A histopathologic study Arch Dermatol 89 1964 46 54
92. M.R. Judge, G. Morgan, and J.I. Harper A clinical and immunological study of Netherton's syndrome Br J Dermatol 131 1994 615 621 (Pubitemid 24344044)
93. S.L. Greene, and S.A. Muller Netherton's syndrome. Report of a case and review of the literature J Am Acad Dermatol 13 1985 329 337 (Pubitemid 16217373)
94. U.W. Schnyder, and K. Wiegand [Hair anomalies in Comel's linear circumflex ichthyosis] [in German] Hautarzt 19 1968 494 499
95. F. Weber, P.G. Fuchs, H.J. Pfister, H. Hintner, P. Fritsch, and R. Hoepfl Human papillomavirus infection in Netherton's syndrome Br J Dermatol 144 2001 1044 1049 (Pubitemid 34203359)
96. V. Sedlacek, and J. Krenar [Symptomatology of Comel's linear circumflex ichthyosis (a case associated with genito-anal papillomatosis)] [in German] Hautarzt 22 1971 390 397
97. H. Hintner, E. Jaschke, and P. Fritsch [Netherton syndrome: weakened immunity, generalized verrucosis and carcinogenesis] [in German] Hautarzt 31 1980 428 432 (Pubitemid 11246149)
98. S. Chavanas, C. Bodemer, A. Rochat, D. Hamel-Teillac, M. Ali, and A.D. Irvine Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome Nat Genet 25 2000 141 142 (Pubitemid 30394980)
99. N. Komatsu, K. Saijoh, A. Jayakumar, G.L. Clayman, M. Tohyama, and Y. Suga Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients J Invest Dermatol 128 2008 1148 1159 (Pubitemid 351543199)
100. N.T. Nehme, J. Pachlopnik Schmid, F. Debeurme, I. Andre-Schmutz, A. Lim, and P. Nitschke MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T cells survival Blood 119 2012 3458 3468
101. H. Abdollahpour, G. Appaswamy, D. Kotlarz, J. Diestelhorst, R. Beier, and A.A. Schaffer The phenotype of human STK4 deficiency Blood 119 2012 3450 3457
102. T.D. Gilmore Introduction to NF-kappaB: players, pathways, perspectives Oncogene 25 2006 6680 6684 (Pubitemid 44657845)
103. A. Jain, C.A. Ma, S. Liu, M. Brown, J. Cohen, and W. Strober Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia Nat Immunol 2 2001 223 228 (Pubitemid 33705998)
104. E. Tobin, A. Rohwedder, S.M. Holland, B. Philips, and J.A. Carlson Recurrent "sterile" verrucous cyst abscesses and epidermodysplasia verruciformis-like eruption associated with idiopathic CD4 lymphopenia Br J Dermatol 149 2003 627 633 (Pubitemid 37281599)
105. E.P. Hanson, L. Monaco-Shawver, L.A. Solt, L.A. Madge, P.P. Banerjee, and M.J. May Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity J Allergy Clin Immunol 122 2008 1169 1177 e16
106. E. Glanzmann, and P. Riniker [Essential lymphocytophthisis; new clinical aspect of infant pathology] Ann Paediatr 175 1950 1 32
107. E.R. Giblett, J.E. Anderson, F. Cohen, B. Pollara, and H.J. Meuwissen Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity Lancet 2 1972 1067 1069
108. F. Cossu Genetics of SCID Ital J Pediatr 36 2010 76
109. L.M. Griffith, M.J. Cowan, L.D. Notarangelo, J.M. Puck, R.H. Buckley, and F. Candotti Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management J Allergy Clin Immunol 124 2009 1152 1160 e12
110. F.C. Antony, A.D. Webster, M.D. Bain, and C.C. Harland Recalcitrant palmoplantar warts associated with adult-onset adenosine deaminase deficiency Br J Dermatol 147 2002 182 183 (Pubitemid 34779461)
111. L.D. Fairbanks, C.L. Shovlin, A.D. Webster, J.M. Hughes, and H.A. Simmonds Adenosine deaminase deficiency with altered biochemical parameters in two sisters with late-onset immunodeficiency J Inherit Metab Dis 17 1994 135 137 (Pubitemid 24110991)
112. C.L. Shovlin, J.M. Hughes, H.A. Simmonds, L. Fairbanks, S. Deacock, and R. Lechler Adult presentation of adenosine deaminase deficiency Lancet 341 1993 1471 (Pubitemid 23161466)
113. C. Laffort, F. Le Deist, M. Favre, S. Caillat-Zucman, I. Radford-Weiss, and M. Debre Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency Lancet 363 2004 2051 2054 (Pubitemid 38781108)
114. A. Marini, T. Niehues, H. Stege, T. Ruzicka, and U.R. Hengge Plantar warts in twins after successful bone marrow transplantation for severe combined immunodeficiency J German Soc Dermatol 4 2006 417 420
115. H. Chapel, M. Lucas, M. Lee, J. Bjorkander, D. Webster, and B. Grimbacher Common variable immunodeficiency disorders: division into distinct clinical phenotypes Blood 112 2008 277 286
116. T.M. Reid, N.G. Fraser, and I.R. Kernohan Generalized warts and immune deficiency Br J Dermatol 95 1976 559 564
117. A. Uluhan, D. Sager, and H.E. Jasin Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia J Rheumatol 25 1998 1205 1210 (Pubitemid 28350899)
118. J. Lynn, A.K. Knight, M. Kamoun, and A.I. Levinson A 55-year-old man with hypogammaglobulinemia, lymphopenia, and unrelenting cutaneous warts J Allergy Clin Immunol 114 2004 409 414 (Pubitemid 39119045)
119. J.H. Lin, K.Y. Wang, S. Kraft, and R.L. Roberts Resolution of warts in association with subcutaneous immunoglobulin in immune deficiency Pediatr Dermatol 26 2009 155 158
120. A.R. Hayward, B.A. Harvey, J. Leonard, M.C. Greenwood, C.B. Wood, and J.F. Soothill Delayed separation of the umbilical cord, widespread infections, and defective neutrophil mobility Lancet 1 1979 1099 1101 (Pubitemid 9184865)
121. C.A. Crowley, J.T. Curnutte, R.E. Rosin, J. Andre-Schwartz, J.I. Gallin, and M. Klempner An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein N Engl J Med 302 1980 1163 1168 (Pubitemid 10109970)
122. D.C. Anderson, and T.A. Springer Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins Annu Rev Med 38 1987 175 194
123. M.A. Arnaout Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response Immunol Rev 114 1990 145 180 (Pubitemid 20141072)
124. G. Uzel, D.E. Kleiner, D.B. Kuhns, and S.M. Holland Dysfunctional LAD-1 neutrphils and colitis Gastroenterology 121 2001 958 964
125. A. Etzioni Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options Adv Exp Med Biol 601 2007 51 60
126. G. Uzel, E. Tng, S.D. Rosenzweig, A.P. Hsu, J.M. Shaw, and M.E. Horwitz Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1) Blood 111 2008 209 218
127. G. Uzel, A.P. Hsu, J. Stoddard, and S.M. Holland The new face of leukocyte adhesion deficiency type 1 (LAD-1) J Clin Immunol 31 2011 S20
128. T.R. Bauer Jr., J.M. Allen, M. Hai, L.M. Tuschong, I.F. Khan, and E.M. Olson Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors Nat Med 14 2008 93 97
129. H.D. Ochs, A.H. Filipovich, P. Veys, M.J. Cowan, and N. Kapoor Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment Biol Blood Marrow Transplant 15 2009 84 90
130. A. Wiskott Familiarer, angeobren Morbus Werlhofi? Monatschrift Kinderheilkd 68 1937 212 216
131. R.A. Aldrich, A.G. Steinberg, and D.C. Campbell Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea Pediatrics 13 1954 133 139
132. L.D. Notarangelo, C.H. Miao, and H.D. Ochs Wiskott-Aldrich syndrome Curr Opin Hematol 15 2008 30 36 (Pubitemid 350191026)
133. K.E. Sullivan, C.A. Mullen, R.M. Blaese, and J.A. Winkelstein A multiinstitutional survey of the Wiskott-Aldrich syndrome J Pediatr 125 1994 876 885 (Pubitemid 24379120)
134. G. Bouma, S.O. Burns, and A.J. Thrasher Wiskott-Aldrich syndrome: immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation Immunobiology 214 2009 778 790
135. Y. Jin, C. Mazza, J.R. Christie, S. Giliani, M. Fiorini, and P. Mella Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation Blood 104 2004 4010 4019 (Pubitemid 39620151)
136. A. Villa, L. Notarangelo, P. Macchi, E. Mantuano, G. Cavagni, and D. Brugnoni X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene Nat Genet 9 1995 414 417
137. L.D. Notarangelo, C. Mazza, S. Giliani, C. D'Aria, F. Gandellini, and C. Ravelli Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia Blood 99 2002 2268 2269 (Pubitemid 34525521)
138. H.D. Ochs, S.J. Slichter, L.A. Harker, W.E. Von Behrens, R.A. Clark, and R.J. Wedgwood The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets Blood 55 1980 243 252 (Pubitemid 10161198)
139. J.S. Orange, N. Ramesh, E. Remold-O'Donnell, Y. Sasahara, L. Koopman, and M. Byrne Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses Proc Natl Acad Sci U S A 99 2002 11351 11356 (Pubitemid 34920929)
140. S. Dupuis-Girod, J. Medioni, E. Haddad, P. Quartier, M. Cavazzana-Calvo, and F. Le Deist Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients Pediatrics 111 2003 e622 e627
141. A.D. Ormerod, A.Y. Finlay, A.G. Knight, N. Mathews, J.M. Stark, and J. Gough Immune deficiency and multiple viral warts: a possible variant of the Wiskott-Aldrich syndrome Br J Dermatol 108 1983 211 215 (Pubitemid 13190111)
142. D.A. Stevens, R.A. Ferrington, T.C. Merigan, and V.A. Marinkovich Randomized trial of transfer factor treatment of human warts Clin Exp Immunol 21 1975 520 524
143. J.K. Kim, M.S. Yoon, J.Y. Huh, H.J. Kim, and D.H. Kim A novel mutation of the WAS gene in a patient with Wiskott-Aldrich syndrome presenting with recalcitrant viral warts J Dermatol Sci 60 2010 120 122
144. A.H. Filipovich, J.V. Stone, S.C. Tomany, M. Ireland, C. Kollman, and C.J. Pelz Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program Blood 97 2001 1598 1603 (Pubitemid 32217223)
145. R. Kobayashi, T. Ariga, S. Nonoyama, H. Kanegane, S. Tsuchiya, and T. Morio Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan Br J Haematol 135 2006 362 366 (Pubitemid 44484844)
146. S.Y. Pai, D. DeMartiis, C. Forino, S. Cavagnini, A. Lanfranchi, and S. Giliani Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation Bone Marrow Transplant 38 2006 671 679 (Pubitemid 44669682)
147. S. Charrier, L. Dupre, S. Scaramuzza, L. Jeanson-Leh, M.P. Blundell, and O. Danos Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients Gene Ther 14 2007 415 428
148. L. Dupre, F. Marangoni, S. Scaramuzza, S. Trifari, R.J. Hernandez, and A. Aiuti Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation Hum Gene Ther 17 2006 303 313
149. A. Galy, and A.J. Thrasher Gene therapy for the Wiskott-Aldrich syndrome Curr Opin Allergy Clin Immunol 11 2011 545 550
150. T.O. Crawford Ataxia telangiectasia Semin Pediatr Neurol 5 1998 287 294 (Pubitemid 29011304)
151. M.F. Lavin, and Y. Shiloh The genetic defect in ataxia-telangiectasia Annu Rev Immunol 15 1997 177 202 (Pubitemid 27169279)
152. E. Boder, and R.P. Sedgwick Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection Pediatrics 21 1958 526 554
153. A.J. Ammann Respiratory complications of ataxia-telangiectasia N Engl J Med 281 1969 1019
154. R.P. Sedgwick, and E. Boder Ataxia-telangiectasia P.J. Vinken, G.W. Bruyn, H.L. Klawans, Handbook of clinical neurology 1991 Elsevier Amsterdam 347 423
155. A. Nowak-Wegrzyn, T.O. Crawford, J.A. Winkelstein, K.A. Carson, and H.M. Lederman Immunodeficiency and infections in ataxia-telangiectasia J Pediatr 144 2004 505 511
156. A.J. Ammann, W.A. Cain, K. Ishizaka, R. Hong, and R.A. Good Immunoglobulin E deficiency in ataxia-telangiectasia N Engl J Med 281 1969 469 472
157. V.A. Oxelius, A.I. Berkel, and L.A. Hanson IgG2 deficiency in ataxia-telangiectasia N Engl J Med 306 1982 515 517 (Pubitemid 12175744)
158. O. Sanal, F. Ersoy, L. Yel, I. Tezcan, A. Metin, and H. Ozyurek Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia J Clin Immunol 19 1999 326 334 (Pubitemid 29489399)
159. A.A. Sadighi Akha, R.L. Humphrey, J.A. Winkelstein, D.M. Loeb, and H.M. Lederman Oligo-/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients Medicine (Baltimore) 78 1999 370 381 (Pubitemid 29534116)
160. R. Paganelli, E. Scala, E. Scarselli, C. Ortolani, A. Cossarizza, and D. Carmini Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia J Clin Immunol 12 1992 84 91
161. M. Carbonari, M. Cherchi, R. Paganelli, G. Giannini, E. Galli, and C. Gaetano Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia N Engl J Med 322 1990 73 76 (Pubitemid 20023863)
162. T.A. Waldmann, S. Broder, C.K. Goldman, K. Frost, S.J. Korsmeyer, and M.A. Medici Disorders of B cells and helper T cells in the pathogenesis of the immunoglobulin deficiency of patients with ataxia telangiectasia J Clin Invest 71 1983 282 295 (Pubitemid 13137492)
163. T.O. Crawford, R.L. Skolasky, R. Fernandez, K.J. Rosquist, and H.M. Lederman Survival probability in ataxia telangiectasia Arch Dis Child 91 2006 610 611 (Pubitemid 44023364)
164. F.S. Rosen, and C.A. Janeway The gamma globulins. 3. The antibody deficiency syndromes N Engl J Med 275 1966 709 715
165. L.D. Notarangelo, and A.R. Hayward X-linked immunodeficiency with hyper-IgM (XHIM) Clin Exp Immunol 120 2000 399 405 (Pubitemid 30365542)
166. M. Herve, I. Isnardi, Y.S. Ng, J.B. Bussel, H.D. Ochs, and C. Cunningham-Rundles CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance J Exp Med 204 2007 1583 1593 (Pubitemid 47048025)
167. F. Facchetti, C. Appiani, L. Salvi, J. Levy, and L.D. Notarangelo Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells J Immunol 154 1995 6624 6633
168. G.G. Yilmaz, E. Yilmaz, M. Coskun, G. Karpuzoglu, T. Gelen, and O. Yegin Cutaneous histoplasmosis in a child with hyper-IgM Pediatr Dermatol 12 1995 235 238
169. M.W. Chang, R. Romero, P.R. Scholl, and A.S. Paller Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome J Am Acad Dermatol 38 1998 191 196 (Pubitemid 28100832)
170. V. Leone, A. Tommasini, M. Andolina, G. Runti, U. De Vonderweid, and C. Campello Elective bone marrow transplantation in a child with X-linked hyper-IgM syndrome presenting with acute respiratory distress syndrome Bone Marrow Transplant 30 2002 49 52
171. J. Thivolet, M.R. Hegazy, J. Viac, and Y. Chardonnet An in vivo study of cell-mediated immunity in human warts. Preliminary results Acta Derm Venereol 57 1977 317 319 (Pubitemid 8159046)
172. J. Viac, J. Thivolet, M.R. Hegazy, Y. Chardonnet, and C. Dambuyant Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV) Clin Exp Immunol 29 1977 240 246 (Pubitemid 8161489)
173. R.G. Fruchter, M. Maiman, A. Sedlis, L. Bartley, L. Camilien, and C.D. Arrastia Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus Obstet Gynecol 87 1996 338 344 (Pubitemid 26075067)
174. J.S. Fennema, E.J. van Ameijden, R.A. Coutinho, and A.A. van den Hoek HIV, sexually transmitted diseases and gynaecologic disorders in women: increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam AIDS 9 1995 1071 1078
175. A.B. Moscicki, J.H. Ellenberg, S. Farhat, and J. Xu Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type J Infect Dis 190 2004 37 45 (Pubitemid 38858402)
176. J. Palefsky Human papillomavirus-related disease in people with HIV Curr Opin HIV AIDS 4 2009 52 56
177. N. Coleman, and M.A. Stanley Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus-related disease of the cervix Cancer 74 1994 884 892 (Pubitemid 24237469)
178. M.A. Stanley, C. Scarpini, and N. Coleman Cell mediated immunity and lower genital tract neoplasia A.B. McClean, A. Singer, H. Critchley, Lower genital tract neoplasia 2003 RCOG press London 27 44
179. M.J. Welters, A. de Jong, S.J. van den Eeden, J.M. van der Hulst, K.M. Kwappenberg, and S. Hassane Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter Cancer Res 63 2003 636 641 (Pubitemid 36158141)
180. M.J. Welters, P. van der Logt, S.J. van den Eeden, K.M. Kwappenberg, J.W. Drijfhout, and G.J. Fleuren Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease Int J Cancer 118 2006 950 956 (Pubitemid 43157670)
181. E.M. Evans, S. Man, A.S. Evans, and L.K. Borysiewicz Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes Cancer Res 57 1997 2943 2950 (Pubitemid 27315044)
182. M. Nakagawa, D.P. Stites, S. Farhat, J.R. Sisler, B. Moss, and F. Kong Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia J Infect Dis 175 1997 927 931 (Pubitemid 27142969)
183. M. Nakagawa, D.P. Stites, J.M. Palefsky, Z. Kneass, and A.B. Moscicki CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses Clin Diagn Lab Immunol 6 1999 494 498 (Pubitemid 29330729)
184. S.J. Lee, Y.S. Cho, M.C. Cho, J.H. Shim, K.A. Lee, and K.K. Ko Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells J Immunol 167 2001 497 504
185. V.R. Bonagura, L.J. Hatam, D.W. Rosenthal, J.A. de Voti, F. Lam, and B.M. Steinberg Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11 APMIS 118 2010 455 470
186. J.J. Carter, L.A. Koutsky, G.C. Wipf, N.D. Christensen, S.K. Lee, and J. Kuypers The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women J Infect Dis 174 1996 927 936 (Pubitemid 26357453)
187. S.C. Fausch, D.M. Da Silva, M.P. Rudolf, and W.M. Kast Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses J Immunol 169 2002 3242 3249 (Pubitemid 35013171)
188. R.W. Tindle Immune evasion in human papillomavirus-associated cervical cancer Nat Rev Cancer 2 2002 59 65 (Pubitemid 37328808)
189. M.A. Stanley Immune responses to human papilloma viruses Indian J Med Res 130 2009 266 276
190. S. Kanodia, L.M. Fahey, and W.M. Kast Mechanisms used by human papillomaviruses to escape the host immune response Curr Cancer Drug Targets 7 2007 79 89 (Pubitemid 46345510)
191. M. Li, H. Lee, J. Guo, F. Neipel, B. Fleckenstein, and K. Ozato Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor J Virol 72 1998 5433 5440 (Pubitemid 28283324)
192. J.A. Mahr, and L.R. Gooding Immune evasion by adenoviruses Immunol Rev 168 1999 121 130 (Pubitemid 29276677)
193. J.A. Symons, A. Alcami, and G.L. Smith Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity Cell 81 1995 551 560
194. C.D. Woodworth, U. Lichti, S. Simpson, C.H. Evans, and J.A. DiPaolo Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells Cancer Res 52 1992 456 463
195. Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011 MMWR Morb Mortal Wkly Rep 60 2011 1705 1708
196. L.E. Markowitz, E.F. Dunne, M. Saraiya, H.W. Lawson, H. Chesson, and E.R. Unger Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 56 2007 1 24
197. J.M. Palefsky, A.R. Giuliano, S. Goldstone, E.D. Moreira Jr., C. Aranda, and H. Jessen HPV vaccine against anal HPV infection and anal intraepithelial neoplasia N Engl J Med 365 2011 1576 1585
198. A.R. Giuliano, J.M. Palefsky, S. Goldstone, E.D. Moreira Jr., M.E. Penny, and C. Aranda Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males N Engl J Med 364 2011 401 411
199. M. Lehtinen, J. Paavonen, C.M. Wheeler, U. Jaisamrarn, S.M. Garland, and X. Castellsague Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol 13 2012 89 99
200. C.M. Wheeler, X. Castellsague, S.M. Garland, A. Szarewski, J. Paavonen, and P. Naud Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol 13 2012 100 110
201. A. Crequer, A. Troeger, and E. Patin Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections J Clin Invest 122 2012 3239 3247